Investable innovation: Tracking remarkable biopharmaceutical advances

Despite recent volatility, opportunities in health care remain abundant, and we believe the long-term outlook for the sector is positive. Powerful demographic trends, a record-setting pace of innovation, and structural changes in health care delivery systems continue to drive growth and expand the investment opportunity set. Wellington Management’s Health Care team currently manages over US$60 billion in assets for clients globally.1 Several team members recently shared their views on advances in the biopharmaceutical industry around the world.